Prestige Consumer Healthcare (PBH) Gross Profit (2010 - 2025)

Prestige Consumer Healthcare's Gross Profit history runs 16 years deep, the most recent figure standing at $157.4 million for Q4 2025.

• On a quarterly basis, Gross Profit fell 2.29% year-over-year to $157.4 million in Q4 2025; TTM through Dec 2025 was $619.3 million, a 0.49% change from a year earlier, with the FY2025 full-year figure at $634.5 million, up 1.6% from the prior year.
• Gross Profit grew to $157.4 million in Q4 2025 per PBH's latest filing, from $151.6 million in the prior quarter.
• Across five years, Gross Profit topped out at $170.0 million in Q1 2025 and bottomed at $137.1 million in Q1 2021.
• The 5-year median for Gross Profit is $156.2 million (2021), against an average of $154.6 million.
• Across the five-year window, Gross Profit gained 18.78% in 2021 and declined 5.59% in 2024, its largest moves.
• Year by year, Gross Profit stood at $155.1 million in 2021, then fell by 3.0% to $150.4 million in 2022, then increased by 5.01% to $157.9 million in 2023, then climbed by 1.97% to $161.0 million in 2024, then slipped by 2.29% to $157.4 million in 2025.
• Per Business Quant, the three latest PBH Gross Profit figures stand at $157.4 million (Q4 2025), $151.6 million (Q3 2025), and $140.3 million (Q2 2025).